MedPath

A lifestyle intervention program for patients with localized prostate cancer - a feasibility study

Not Applicable
Conditions
C61
Malignant neoplasm of prostate
Registration Number
DRKS00005795
Lead Sponsor
niversität Duisburg-EssenLehrstuhl und Klinik für Naturheilkund und Integrative Medizin, Knappschafts-Krankenhaus,Kliniken Essen-Mitte
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Male
Target Recruitment
17
Inclusion Criteria

• PSA = 10 ng/ml
• Gleason-Score = 6
• cT1c and cT2a
• tumor in = 2 punch biopsies (min. 8 punch biopsies )
• = 50 % tumor / punch biopsy
• life expectancy min. 10 yrs
• Karnofsky-Index min. 80% or ECOG-Performance-Status 0-2
• written informed consent

Exclusion Criteria

• previous or planned partial oder radical prostatectomy
• unsufficient knowledge of German language,
• severe physical or psychological diseases that may constrain patients
• systemic-neurological diseases (MS, parkinson, dementia).

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
compliance / adherence during intervention period (diary, attendance time)
Secondary Outcome Measures
NameTimeMethod
questionnaires:<br>HRQoL (FACT-G, FACT-P)<br>anxiety (STAI)<br>depression (BDI)<br>mindfulness (FFA)<br>stress (PSS)<br>barriers<br>lifestly<br>coping (COPE)<br><br>Other:<br>saliva cortisol<br>pro- and anti-inflammatory cytonkines (plasma)<br><br>all post-intervention (11 weeks)<br><br>
© Copyright 2025. All Rights Reserved by MedPath